Real-time enrollment status for this muscular atrophy, spinal clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:15 AM UTC
| NCT Number | NCT07221669 |
| Recruiting Status | Recruiting |
| Condition | Muscular Atrophy, Spinal |
| Phase | PHASE3 |
| Target Enrollment | 30 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Biogen |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07221669 is currently recruiting participants. This phase3 study for muscular atrophy, spinal is actively seeking new participants at 3 locations across the United States. The study is sponsored by Biogen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221669 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221669 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.